Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above

NCT05636436 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Low Dose Recombinant Herpes Zoster Vaccine (CHO cells)
BIOLOGICAL: High Dose Recombinant Herpes Zoster Vaccine (CHO cells)
BIOLOGICAL: Low dose adjuvant
BIOLOGICAL: High dose adjuvant
BIOLOGICAL: Positive control
BIOLOGICAL: Placebo

Sponsor

MAXVAX Biotechnology Limited Liability Company

Collaborators

[object Object]